SavedAdd your journal

Journals / Journal of Basic and Clinical Health Sciences / 2019 / Cilt: 3 - Sayı: 3

Evaluation of Changes in The Hematological Parameters, Lipid Profile and Depressive Symptoms Before and After Smoking Cessation Treatment

Fatma DAĞISTAN
Ruhuşen KUTLU
Pages
170–176
Publication Date
2019-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After quitting smoking, the Beck Depression Scores BDS decreased significantly p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Tobacco dependence is a cluster of behavioural, cognitive, and physiological phenomena.
📊
Key Findings & Data:We aimed to investigate the changes in the hematological parameters, lipid profile and depressive symptoms before and after smoking cessation.Methods: In this intervention study, 150 cases admitted to the clinic to quit smoking and stopped smoking for at least three months were investigated.
💡
Conclusion & Impact:After quitting smoking, the Beck Depression Scores BDS decreased significantly p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Smoking cessation · hematological parameters · lipid profile

Abstract

Introduction: Tobacco dependence is a cluster of behavioural, cognitive, and physiological phenomena. We aimed to investigate the changes in the hematological parameters, lipid profile and depressive symptoms before and after smoking cessation.Methods: In this intervention study, 150 cases admitted to the clinic to quit smoking and stopped smoking for at least three months were investigated. All participants have received motivational interview and appropriate medical treatment varenicline, bupropion, nicotine replacement therapy . We designed the study to evaluate the effects of cigarette smoking on some biochemical markers and depressive symptoms.Results: Motivational interviews were conducted on all participants, and 68,7% n = 103 were treated with varenicline, 19,3% n=29 with bupropion and 12% n=18 with nicotine replacement therapy NRT . There was a statistically significant relationship between the treatment method and the smoking cessation duration p=0.002 . Cessation period was longer in the group using varenicline. After quitting smoking, the Beck Depression Scores BDS decreased significantly p

🔖

Cite This Article

DAĞISTAN, F., KUTLU, R. (2019). Evaluation of Changes in The Hematological Parameters, Lipid Profile and Depressive Symptoms Before and After Smoking Cessation Treatment. Journal of Basic and Clinical Health Sciences, Cilt: 3 - Sayı: 3, 170–176. https://ajindex.com/articles/163591

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. The health consequences of smoking: A report of the Surgeon General. Atlanta. GA: Center for Disease Control and Prevention. Office of Smoking and Health. Available from: http:/www.ncbi.nlm. nih.gov/pubmed/20669512. Accessed 30.02.2018. World Health Organization. WHO report on the global tobacco epidemic 2013 [Updated 2013; cited 2014 Oct 30]. Available from: http://www.who.int/tobacco/global_report/2013/en/ Accessed 20.01.2018.
  2. Global adult tobacco survey, Ankara, Turkey 2012 [cited 2018 Jan 30]. Available from: http://www.who.int/tobacco/surveillance/survey/ gats/report_tur_2012.pdf?ua=1 Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL. Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol. 2001;38:1633-8. [CrossRef] Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis. 2003;46:91-111.
  3. Attard R, Dingli P, Doggen CJM, Cassar K, Farrugia R, Wettinger SB. The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction. Open Heart. 2017;4:e000620. [CrossRef] Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis M, Pita E, Maltezos E, Bouros D. Mean platelet volume and platelet distribution width in patients with chronic obstructivepulmonary disease: the role of comorbidities. Angiology. 2013;64:535-9. [CrossRef] Malenica M, Prnjavorac B, Bego T, Dujic T, Semiz S, Skrbo S, Gusic A, Hadzic A, Causevic A. Effect of Cigarette Smoking on Haematological Parameters in Healthy Population. Med Arch 2017;71:132-136. [CrossRef] Brown C, Madden PA, Palenchar DR, Cooper-Patrick L.The association between depressive symptoms and cigarette smoking in an urban primary care sample. Int J Psychiatry Med. 2000;30:15-26. [CrossRef] Balfour DJ, Ridley DL. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Pharmacol Biochem Behav. 2000;66:79-85. [CrossRef] Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J. 1990;69:763-65.
  4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71. [CrossRef] Komiyama M, Shimada S, Wada H, Yamakage H, Satoh-Asahara N, Shimatsu A, Akao M, Morimoto T, Takahashi Y, Hasegawa K. Time- dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation. J Atheroscler Thromb. 2016;23:1270-1275. [CrossRef] Vizioli L, Mu